Search Results - Daniel T. Merrick
- Showing 1 - 4 results of 4
-
1
Tracheal dysplasia precedes bronchial dysplasia in mouse model of N-nitroso trischloroethylurea induced squamous cell lung cancer. by Moumita Ghosh, Lori D Dwyer-Nield, Jennifer B Kwon, Lea Barthel, William J Janssen, Daniel T Merrick, Robert L Keith
Published in PLoS ONE (2015-01-01)Get full text
Article -
2
A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer by Natalia J. Gurule, Caroline E. McCoach, Trista K. Hinz, Daniel T. Merrick, Adriaan Van Bokhoven, Jihye Kim, Tejas Patil, Jacob Calhoun, Raphael A. Nemenoff, Aik Choon Tan, Robert C. Doebele, Lynn E. Heasley
Published in npj Precision Oncology (2021-05-01)Get full text
Article -
3
Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment by York E. Miller, York E. Miller, Moumita Ghosh, Daniel T. Merrick, Brandi Kubala, Eva Szabo, Lisa Bengtson, Masha Kocherginsky, Irene B. Helenowski, Kelly Benante, Tia Schering, Jihye Kim, Hyunmin Kim, Duc Ha, Raymond C. Bergan, Seema A. Khan, Robert L. Keith, Robert L. Keith
Published in Frontiers in Oncology (2023-08-01)Get full text
Article -
4
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity by Emily K. Kleczko, Trista K. Hinz, Teresa T. Nguyen, Natalia J. Gurule, Andre Navarro, Anh T. Le, Amber M. Johnson, Jeff Kwak, Diana I. Polhac, Eric T. Clambey, Mary Weiser-Evans, Daniel T. Merrick, Michael C. Yang, Tejas Patil, Erin L. Schenk, Lynn E. Heasley, Raphael A. Nemenoff
Published in npj Precision Oncology (2023-02-01)Get full text
Article
